Reduction of allergy burden in preventive and active treatment. Airway hyperresponsiveness, eosinophilia, IgE, goblet cell hyperplasia and Th2 cytokines reduction. IL-10 and CD4+ Foxp3+ regulatory T cells increase. The gene discussed is FOXP3; the disease is allergic disease.